福沙吡坦

更新时间：2024-01-05 16:48:23

福沙吡坦结构式	常用名	福沙吡坦	英文名	Fosaprepitant
	CAS号	172673-20-0	分子量	614.407
	密度	1.7±0.1 g/cm3	沸点	588.9ºC at 760 mmHg
	分子式	C₂₃H₂₂F₇N₄O₆P	熔点	N/A
	MSDS	N/A	闪点	310ºC

福沙吡坦用途

Fosaprepitant(L-758298)是神经激肽-1受体水溶性拮抗剂，可作用于化疗引起的恶心呕吐。

中文名	福沙吡坦
英文名	fosaprepitant
中文别名	福沙匹坦 \| 福沙匹坦二甲基葡胺 \| [3-[[(2R,3S)-2-[(1R)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-吗啉基]甲基]-2,5-二氢-5-氧代-1H-1,2,4-三唑-1-基]膦酸 \| 福沙匹坦 /福沙匹坦二葡甲胺
英文别名	更多

描述	Fosaprepitant(L-758298)是神经激肽-1受体水溶性拮抗剂,可作用于化疗引起的恶心呕吐。
相关类别	信号通路 >> G 蛋白偶联受体/G 蛋白 >> 神经激肽受体信号通路 >> 神经信号通路 >> 神经激肽受体研究领域 >> 神经疾病
参考文献	[1]. Navari RM. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2008 Nov;8(11):1733-42. [2]. Olver IN. Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant. Ther Clin Risk Manag. 2008 Apr;4(2):501-6. [3]. Grunberg S, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE. J Clin Oncol. 2011 Apr 10;29(11):1495-501. [4]. Saito H, et al. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Ann Oncol.

描述

Fosaprepitant(L-758298)是神经激肽-1受体水溶性拮抗剂,可作用于化疗引起的恶心呕吐。

相关类别

信号通路 >> G 蛋白偶联受体/G 蛋白 >> 神经激肽受体

信号通路 >> 神经信号通路 >> 神经激肽受体

研究领域 >> 神经疾病

参考文献

[1]. Navari RM. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Expert Rev Anticancer Ther. 2008 Nov;8(11):1733-42.

[2]. Olver IN. Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant. Ther Clin Risk Manag. 2008 Apr;4(2):501-6.

[3]. Grunberg S, et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE. J Clin Oncol. 2011 Apr 10;29(11):1495-501.

[4]. Saito H, et al. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Ann Oncol.

密度	1.7±0.1 g/cm3
沸点	588.9ºC at 760 mmHg
分子式	C₂₃H₂₂F₇N₄O₆P
分子量	614.407
闪点	310ºC
精确质量	614.116516
PSA	139.72000
LogP	2.14
蒸汽压	1.03E-14mmHg at 25°C
折射率	1.590
储存条件	2-8℃

[5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-3-oxo-1H-1,2,4-triazol-2-yl]phosphonic acid

Phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-4,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-

6L8OF9XRDC

(3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-4-morpholinyl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

Emend IV

L-758,298

Fosaprepitant

UNII-6L8OF9XRDC